F. D. Russell

Publication List Details

Period

2000 - 2009

Number

55

Co-Authors

The Role of Brain Stem Death and Ischemia Reperfusion Injury in the Alteration of the Endothelin and RAS Pathways Pre and Post Lung Transplantation (2009)

Passmore, M, Nataatmadja, M, Russell, F D, Corley, A, Venz, E, Hopkins, P, ...

No abstract available. Presented at the International Society for Heart and Lung Transplantation Twenty-Ninth Annual Meeting and Scientific Sessions, Paris, France, 22-25 April 2009.

The blood flow and fatigue response to isometric plantar-flexion exercise in patients with peripheral arterial disease (2009)

Stefanovic, B, Russell, F D, Walker, P J, Green, S, Askew, C D

Introduction: The aim of the present study was to assess the relationship between blood flow and fatigue during lower limb plantar-flexion exercise in peripheral arterial disease (PAD) and age...

Urotensis II in cardiovascular regulation (2008)

Russell, F D

Cardiovascular function is modulated by neuronal transmitters, circulating hormones, and factors that are released locally from tissues. Urotensin II (UII) is an 11 amino acid peptide that stimulates...

Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II (2005)

Li, J., Wang, J. C., Russell, F. D., Molenaar, P.

1 The calcineurin (CaN) enzyme-transcriptional pathway is critically involved in hypertrophy of heart muscle in some animal models. Currently there is no information concerning the regulation of CaN...

Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II (2005)

Li, J., Wang, J. C., Russell, F. D., Molenaar, P.

1 The calcineurin (CaN) enzyme-transcriptional pathway is critically involved in hypertrophy of heart muscle in some animal models. Currently there is no information concerning the regulation of CaN...

Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II (2005)

Li, J, Wang, J, Russell, F D, Molenaar, P

The calcineurin (CaN) enzyme–transcriptional pathway is critically involved in hypertrophy of heart muscle in some animal models. Currently there is no information concerning the regulation of CaN...

Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro (2004)

Russell, F. D., Kearns, P., Toth, I., Molenaar, P.

Human urotensin-II (hU-II) is processed from its prohormone (ProhU-II) at putative cleavage sites for furin and serine proteases such as trypsin. Although proteolysis is required for biological...

Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro (2004)

Russell, F. D., Kearns, P., Toth, I., Molenaar, P.

Human urotensin-II (hU-II) is processed from its prohormone (ProhU-II) at putative cleavage sites for furin and serine proteases such as trypsin. Although proteolysis is required for biological...

Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart (2004)

Russell, F D, Molenaar, P

Objective: This study investigated signaling pathways that may contribute to the potent positive inotropic effect of human urotensin-II (hU-II) in human isolated right atrial trabeculae obtained from...

Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro (2004)

Russell, F D, Kearns, P, Toth, I, Molenaar, P

Human urotensin-II (hU-II) is processed from its prohormone (ProhU-II) at putative cleavage sites for furin and serine proteases such as trypsin. Although proteolysis is required for biological...

Emerging roles of urotensin-II in cardiovascular disease (2004)

Russell, F D

Urotensin-II (UII) is a highly potent endogenous peptide within the cardiovascular system. Through stimulation of Gαq-coupled UT receptors, UII mediates contraction of vascular smooth muscle and...

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure (2003)

Russell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S., ...

Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date. We therefore determined whether hU-II has a possible pathological role by investigating its levels in...

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure (2003)

Russell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S., ...

Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date. We therefore determined whether hU-II has a possible pathological role by investigating its levels in...

(-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the β-adrenoceptor (2003)

Sarsero, D, Russell, F D, Lynham, J A, Rabnott, G, Yang, I, Fong, K M, ...

Two forms of the activated #1-adrenoceptor exist, one that is stabilized by (-)-noradrenaline and is sensitive to blockade by (-)-propranolol and another which is stabilized by partial agonists such...

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure (2003)

Russell, F D, Meyers, D, Galbraith, A J, Bett, N, Toth, I, Kearns, P, ...

Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date. We therefore determined whether hU-II has a possible pathological role by investigating its levels in...

Conservation of the cardiostimulant effects of (-)-Norepinephrine across Ser49Gly and Gly389Arg Beta1-adrenergic receptor polymorphisms in human right atrium in vitro (2002)

Molenaar, P., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L., ...

OBJECTIVES The goal of this study was to determine whether the cardiostimulant effects of the endogenous beta(1)-adrenergic receptor (AR) agonist, (-)-norepinephrine are modified by polymorphic...

Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta1-adrenergic receptor polymorphisms in human right atrium in vitro (2002)

Molenaar, P, Robnott, G, Yang, I, Fong, K, Savarimuthu, S M, Li, L, ...

Objectives: The goal of this study was to determine whether the cardiostimulant effects of the endogenous beta1-adrenergic receptor (AR) agonist, (−)-norepinephrine are modified by polymorphic...

Cardiostimulant effects of urotensin-II in human heart in vitro (2001)

Russell, F D, Molenaar, P, O'Brien, D

The effects of the recently identified human peptide urotensin-II (hU-II) were investigated on human cardiac muscle contractility and coronary artery tone. In right atrial trabeculae from non-failing...

Characterization and localization of atypical beta-adrenoceptors in rat ileum.

Roberts, S. J., Russell, F. D., Molenaar, P., Summers, R. J.

1. Homogenate binding studies and receptor autoradiography have been used to examine the binding characteristics and localization of propranolol-resistant (-)-[125I]-cyanopindolol (CYP) binding sites...

Characterization of the binding of endothelin ETB selective ligands in human and rat heart.

Russell, F. D., Davenport, A. P.

1. We determined competition binding characteristics of endothelin ETB receptor selective ligands in human left ventricle and compared these values to those obtained with rat left ventricle....